Specific Target Organ Toxicity – Single exposure, category 3
Risk Statements
36/37/38
RTECS
TX1413500
European Hazard Symbols
Irritant (Xi)
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Physical Property
Apperance
powder
Solubility
H2O: insoluble
DMSO: >5 mg/mL
Product Information
Empirical Formula (Hill Notation)
C18H14F4N2O4S
Purity
≥98% (HPLC)
Molecule Details
Biochem/physiol Actions Bicalutamide (CDX) is a non-steriodal Androgen Receptor (AR) antagonist and a pure antiandrogen. It acts via balancing histone acetylation/deacetylation and recruitment of coregulators. Bicalutamide (CDX) abolishes androgen-mediated expression. For example, MMP13 upregulation in prostate cancer, PLZF (promyelocytic leukemia zinc finger protein), and GADD45γ (growth arrest and DNA damage inducible, gamma). Bicalutamide (CDX) is inhibited by non-genomic, transcription-independent stimulation of PI3K/AKT phosphorylation by androgens.